Stockreport

Lyra Therapeutics GAAP EPS of -$1.43 misses by $0.10, revenue of $1.53M [Seeking Alpha]

Lyra Therapeutics, Inc.  (LYRA) 
PDF Lyra Therapeutics press release NASDAQ: LYRA ): FY GAAP EPS of -$1.43 misses by $0.10 Collaboration revenue of $1.53M (-1.9% Y/Y). [Read more]